Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The syphilis immunoassay diagnostics market size in the 7 major markets was valued at USD 411.4 million in 2023, driven by the incidence of syphilis cases in the major markets. The market is expected to grow at a CAGR of 3.0% during the forecast period of 2024-2032, with the values likely to rise from USD 423.6 million in 2024 to USD 534.9 million by 2032.
Syphilis immunoassay is a type of diagnostic method used to check if a patient is affected with syphilis. Syphilis is a bacterial infection. It is a sexually transmitted disease which spreads through oral, vaginal, or anal sexual contact. It may even pass down from a pregnant woman to the fetus.
The diagnosis is done via measuring certain antibody levels in the blood. It can be done through a blood test called rapid plasma regain (RPR) or through a blood or spinal fluid test called venereal disease research laboratory (VDRL) test.
Syphilis is the oldest known sexually transmitted disease, affecting a substantial portion of adults, falling in the age category of 15 to 49 years. Over the years, the incidence of Syphilis cases has increased by 32%. Therefore, there has been emphasis on diagnosing, preventing, and treating the disease. This has resulted in an increased syphilis immunoassay diagnostics market demand.
Syphilis is caused by the gram-negative bacterium Treponema pallidum. Currently, most of the syphilis detection is investigated through T. pallidum IgG chemiluminescence immunoassay (CLIA), which is a qualitative assay performed to detect the antibodies against the bacteria in the body. Owing to the array of CLIA applications, Fapon Biotech has developed around 80 different CLIA tests. The CLIA Analyzer Shine i8000/9000 produces high outputs for rapid and reliable clinical diagnosis. It does not require any extensive maintenance either. Therefore, the syphilis immunoassay diagnostics market value is certain to rise with such technologies.
As syphilis can also be transmitted to newborns via mother, there has been focus on preventing developing methods to detect congenital syphilis in children. The researchers from UTHealth Houston are developing a medical diagnostic test for the detection of congenital syphilis to facilitate early treatment. This method can turn out to be promising in the future as 60% of untreated syphilis infected infants suffer from neurodevelopmental issues.
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by End User
Market Breakup by Region
The United States is expected to lead the syphilis immunoassay diagnostics market share. As sexually transmitted diseases continue to rise in the region, the government has been setting several awareness campaigns to spread awareness and prevent the illness. ‘Girl, Get Tested’ is a notable public awareness campaign promoting syphilis screening in cisgender women. In addition, the United States also has prominent healthcare companies which continue to bring newer technologies.
The Asia Pacific region, especially Japan, is estimated to observe fastest growth, owing to the increasing prevalence of developing a well-equipped infrastructure for research and development. The syphilis immunoassay diagnostics market growth can be accredited to several awareness initiatives. For example, in March 2023, the Australian government initiated ‘Let your partners know’ syphilis awareness campaign envisioned to encourage contact tracing for people who have tested positive to syphilis. The aim is to ultimately increase syphilis testing and treatment.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 411.4 million in 2023, driven by the incidence of syphilis cases in the major markets.
The market is anticipated to grow at a CAGR of 3.0% during the forecast period of 2024-2032, likely to reach a market value of USD 534.9 million by 2032.
The growth of the market is driven by the rising emphasis on early detection of the diseases and the growing initiatives by the government.
The market has been flourished with new products that offer accurate and rapid results. For instance, Fapon Biotech has developed CLIA Analyzer Shine i8000/9000 for high outputs. It does not need any extra maintenance either.
The major regions of the market include United States, Japan, and EU-4 and the United Kingdom. EU-4 includes Germany, France, Italy, and Spain.
CLIA and ELISA, among others are different types of technologies available.
Products include analyzers, kits, and reagents.
Major end users include hospitals, diagnostic labs, and blood banks, among others.
Key players involved in the market are BioRad Laboratories Inc., Danaher Corporation, BECTON DICKINSON & COMPANY, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Diasorin S.P.A, Abbott, Fujirebio, Shenzhen New Industries Biomedical Engineering Co. Ltd., and BioMerieux SA.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share